71:
40:
167:
The median survival of primary peritoneal carcinomas is usually shorter by 2–6 months time when compared with serous ovarian cancer. Studies show median survival varies between 11.3 and 17.8 months. One study reported 19–40 month median survival (95% CI) with a five-year survival of 26.5%.
471:
452:
87:
is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma, and psammomacarcinoma. It was historically classified under
114:, which include ovarian serous carcinoma, uterine serous carcinoma, fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
403:
Alphs HH, Zahurak ML, Bristow RE, DĂaz-Montes TP (December 2006). "Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer".
295:
525:
188:
Jaaback KS, Ludeman L, Clayton NL, Hirschowitz L (2006). "Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period".
756:
781:
322:"Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study"
518:
228:
1006:
866:
126:
has been described. Furthermore, women with BRCA1/2 mutation have a 5% risk of developing primary peritoneal cancer even after prophylactic
299:
1055:
1011:
511:
149:
618:
914:
361:
1016:
819:
776:
747:
727:
719:
632:
542:
89:
985:
761:
737:
723:
1001:
742:
596:
104:, or abdominal cavity. It usually affects women and is diagnosed after the age of 60; it very rarely affects men.
909:
838:
534:
320:
Burger, Robert A.; Sill, Michael W.; Monk, Bradley J.; Greer, Benjamin E.; Sorosky, Joel I. (20 November 2007).
861:
715:
486:
1050:
799:
568:
891:
679:
641:
551:
134:
751:
896:
70:
475:
1076:
956:
938:
878:
707:
703:
209:
1023:
975:
966:
689:
591:
560:
420:
343:
277:
201:
59:
362:"New Drug Combination for Ovarian and Primary Peritoneal Cancers - National Cancer Institute"
824:
698:
613:
601:
412:
333:
267:
259:
193:
160:
Prognosis and treatment is the same as for the most common type of ovarian cancer, which is
111:
51:
39:
666:
649:
386:
980:
943:
873:
771:
711:
654:
583:
573:
365:
272:
247:
107:
97:
263:
1070:
924:
606:
296:"Gynecologic Cancer Treatment—Primary Peritoneal Cancer—Dana-Farber Cancer Institute"
197:
123:
480:
17:
886:
213:
127:
491:
951:
904:
847:
791:
416:
1037:
465:
461:
171:
Elevated albumin levels have been associated with a more favorable prognosis.
161:
101:
47:
503:
338:
321:
933:
856:
674:
391:
145:) as ovarian cancer and can also show an increased expression of HER-2/neu.
424:
347:
281:
205:
122:
Although the precise causes are not known, a link with certain variants of
996:
64:
444:
456:
93:
993:
507:
142:
138:
92:" (CUP). Primary peritoneal cancer (PPC, or PPCa) is a
110:
and molecular biological characteristics suggest that
434:
133:
Primary peritoneal carcinoma shows similar rates of
1036:
965:
923:
846:
837:
812:
790:
688:
665:
640:
631:
582:
559:
550:
541:
438:
58:
32:
248:"The cell of origin of ovarian epithelial tumours"
519:
8:
54:, which may arise from the peritoneal lining
843:
637:
556:
547:
526:
512:
504:
435:
69:
38:
29:
782:Hereditary nonpolyposis colorectal cancer
337:
271:
1007:Intraductal papillary mucinous neoplasm
180:
7:
1056:Desmoplastic small round cell tumor
757:Polymerase proofreading-associated
150:vascular endothelial growth factor
25:
619:Hereditary diffuse gastric cancer
227:Type, Cancer (21 February 2022).
915:Nodular regenerative hyperplasia
198:10.1111/j.1525-1438.2006.00474.x
1017:Solid pseudopapillary neoplasm
820:Gastrointestinal stromal tumor
777:Familial adenomatous polyposis
1:
825:Krukenberg tumor (metastatic)
264:10.1016/S1470-2045(08)70308-5
1046:Primary peritoneal carcinoma
720:traditional serrated adenoma
326:Journal of Clinical Oncology
90:carcinoma of unknown primary
33:Primary peritoneal carcinoma
986:Pancreatic ductal carcinoma
417:10.1016/j.ygyno.2006.06.019
229:"Primary peritoneal cancer"
1093:
1002:Serous microcystic adenoma
597:Signet ring cell carcinoma
535:Digestive system neoplasia
910:Focal nodular hyperplasia
81:Primary peritoneal cancer
46:
37:
1012:Mucinous cystic neoplasm
862:Hepatocellular carcinoma
716:sessile serrated adenoma
339:10.1200/JCO.2007.11.5345
1051:Peritoneal mesothelioma
800:Squamous cell carcinoma
569:Squamous cell carcinoma
246:Dubeau, L. (Dec 2008).
190:Int. J. Gynecol. Cancer
892:Hepatocellular adenoma
680:Pseudomyxoma peritonei
192:. 16 Suppl 1: 123–8.
135:tumor suppressor gene
897:Cavernous hemangioma
748:Familial adenomatous
735:Polyposis syndromes:
148:An association with
18:Peritoneal neoplasms
152:has been observed.
957:Gallbladder cancer
939:Cholangiocarcinoma
879:Liver angiosarcoma
813:Upper and/or lower
762:Serrated polyposis
233:Cancer Research UK
108:Histomorphological
1064:
1063:
1032:
1031:
1024:Pancreatoblastoma
976:exocrine pancreas
833:
832:
808:
807:
627:
626:
592:Gastric carcinoma
501:
500:
387:Peritoneal Cancer
332:(33): 5165–5171.
112:serous carcinomas
78:
77:
27:Medical condition
16:(Redirected from
1084:
844:
743:MUTYH-associated
728:Cronkhite–Canada
699:Colorectal polyp
638:
614:Linitis plastica
602:Gastric lymphoma
557:
548:
528:
521:
514:
505:
436:
429:
428:
400:
394:
383:
377:
376:
374:
373:
364:. Archived from
358:
352:
351:
341:
317:
311:
310:
308:
307:
298:. Archived from
292:
286:
285:
275:
243:
237:
236:
224:
218:
217:
185:
164:ovarian cancer.
74:
73:
52:serous carcinoma
42:
30:
21:
1092:
1091:
1087:
1086:
1085:
1083:
1082:
1081:
1067:
1066:
1065:
1060:
1028:
961:
919:
829:
804:
786:
684:
661:
650:Duodenal cancer
642:Small intestine
623:
578:
537:
532:
502:
497:
496:
447:
433:
432:
402:
401:
397:
384:
380:
371:
369:
360:
359:
355:
319:
318:
314:
305:
303:
294:
293:
289:
245:
244:
240:
226:
225:
221:
187:
186:
182:
177:
158:
120:
68:
28:
23:
22:
15:
12:
11:
5:
1090:
1088:
1080:
1079:
1069:
1068:
1062:
1061:
1059:
1058:
1053:
1048:
1042:
1040:
1034:
1033:
1030:
1029:
1027:
1026:
1020:
1019:
1014:
1009:
1004:
989:
988:
983:
981:Adenocarcinoma
971:
969:
963:
962:
960:
959:
947:
946:
944:Klatskin tumor
941:
929:
927:
921:
920:
918:
917:
912:
900:
899:
894:
882:
881:
876:
874:Hepatoblastoma
871:
870:
869:
852:
850:
841:
835:
834:
831:
830:
828:
827:
822:
816:
814:
810:
809:
806:
805:
803:
802:
796:
794:
788:
787:
785:
784:
779:
774:
772:Adenocarcinoma
765:
764:
759:
754:
745:
740:
731:
730:
694:
692:
686:
685:
683:
682:
677:
671:
669:
663:
662:
660:
659:
658:
657:
655:Adenocarcinoma
646:
644:
635:
629:
628:
625:
624:
622:
621:
616:
611:
610:
609:
599:
594:
588:
586:
580:
579:
577:
576:
574:Adenocarcinoma
571:
565:
563:
554:
545:
539:
538:
533:
531:
530:
523:
516:
508:
499:
498:
495:
494:
483:
468:
448:
443:
442:
440:
439:Classification
431:
430:
411:(3): 1048–53.
405:Gynecol. Oncol
395:
378:
353:
312:
287:
258:(12): 1191–7.
238:
219:
179:
178:
176:
173:
157:
154:
119:
118:Genetic causes
116:
76:
75:
62:
56:
55:
44:
43:
35:
34:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1089:
1078:
1075:
1074:
1072:
1057:
1054:
1052:
1049:
1047:
1044:
1043:
1041:
1039:
1035:
1025:
1022:
1021:
1018:
1015:
1013:
1010:
1008:
1005:
1003:
999:
998:
995:
991:
990:
987:
984:
982:
979:
977:
973:
972:
970:
968:
964:
958:
955:
953:
949:
948:
945:
942:
940:
937:
935:
931:
930:
928:
926:
925:Biliary tract
922:
916:
913:
911:
908:
906:
902:
901:
898:
895:
893:
890:
888:
884:
883:
880:
877:
875:
872:
868:
867:Fibrolamellar
865:
864:
863:
860:
858:
854:
853:
851:
849:
845:
842:
840:
836:
826:
823:
821:
818:
817:
815:
811:
801:
798:
797:
795:
793:
789:
783:
780:
778:
775:
773:
770:
767:
766:
763:
760:
758:
755:
753:
749:
746:
744:
741:
739:
736:
733:
732:
729:
725:
724:Peutz–Jeghers
721:
717:
713:
709:
705:
702:
700:
696:
695:
693:
691:
687:
681:
678:
676:
673:
672:
670:
668:
664:
656:
653:
652:
651:
648:
647:
645:
643:
639:
636:
634:
630:
620:
617:
615:
612:
608:
607:MALT lymphoma
605:
604:
603:
600:
598:
595:
593:
590:
589:
587:
585:
581:
575:
572:
570:
567:
566:
564:
562:
558:
555:
553:
549:
546:
544:
540:
536:
529:
524:
522:
517:
515:
510:
509:
506:
493:
489:
488:
484:
482:
478:
477:
473:
469:
467:
463:
459:
458:
454:
450:
449:
446:
441:
437:
426:
422:
418:
414:
410:
406:
399:
396:
393:
389:
388:
382:
379:
368:on 2010-12-24
367:
363:
357:
354:
349:
345:
340:
335:
331:
327:
323:
316:
313:
302:on 2008-04-29
301:
297:
291:
288:
283:
279:
274:
269:
265:
261:
257:
253:
249:
242:
239:
234:
230:
223:
220:
215:
211:
207:
203:
199:
195:
191:
184:
181:
174:
172:
169:
165:
163:
155:
153:
151:
146:
144:
140:
137:dysfunction (
136:
131:
129:
125:
117:
115:
113:
109:
105:
103:
99:
95:
91:
86:
82:
72:
66:
63:
61:
57:
53:
49:
45:
41:
36:
31:
19:
1045:
992:
974:
950:
932:
903:
885:
855:
768:
734:
708:hyperplastic
697:
690:Colon/rectum
485:
470:
451:
408:
404:
398:
385:
381:
370:. Retrieved
366:the original
356:
329:
325:
315:
304:. Retrieved
300:the original
290:
255:
252:Lancet Oncol
251:
241:
232:
222:
189:
183:
170:
166:
159:
147:
132:
128:oophorectomy
121:
106:
84:
80:
79:
952:gallbladder
905:hyperplasia
100:lining the
1038:Peritoneum
372:2008-05-07
306:2008-05-07
175:References
162:epithelial
102:peritoneum
48:Micrograph
1077:Carcinoma
997:neoplasms
934:bile duct
857:malignant
839:Accessory
769:Neoplasm:
752:Gardner's
675:Carcinoid
561:Esophagus
392:eMedicine
156:Prognosis
85:carcinoma
60:Specialty
1071:Category
967:Pancreas
738:Juvenile
712:juvenile
667:Appendix
543:GI tract
425:16876237
348:18024863
282:19038766
206:16515579
141:, BRCA,
65:Oncology
704:adenoma
584:Stomach
492:D010534
273:4176875
214:2907689
124:BRCA1/2
96:of the
994:cystic
887:benign
423:
346:
280:
270:
212:
204:
94:cancer
67:
848:Liver
633:Lower
552:Upper
466:C48.2
462:C48.1
210:S2CID
98:cells
50:of a
792:Anus
487:MeSH
476:9-CM
421:PMID
344:PMID
278:PMID
202:PMID
481:158
472:ICD
453:ICD
413:doi
409:103
390:at
334:doi
268:PMC
260:doi
194:doi
143:WT1
139:p53
83:or
1073::
1000::
726:,
722:,
718:,
714:,
710:,
706:,
490::
479::
460::
457:10
419:.
407:.
342:.
330:25
328:.
324:.
276:.
266:.
254:.
250:.
231:.
208:.
200:.
130:.
978::
954::
936::
907::
889::
859::
750:/
701::
527:e
520:t
513:v
474:-
464:-
455:-
445:D
427:.
415::
375:.
350:.
336::
309:.
284:.
262::
256:9
235:.
216:.
196::
88:"
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
